Letermovir prophylaxis lowers the incidence of Non-CMV infections after allogeneic hematopoietic cell transplantation

Affiliations

¹ The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
² Blood and Marrow Transplant Program at Northside Hospital, Atlanta Georgia, GA, USA.
³ Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
⁴ Blood and Marrow Transplant Program at Northside Hospital, Atlanta Georgia, GA, USA. msolh@bmtga.com.

Saffiya Z Bashey et al. Bone Marrow Transplant. 2024 Apr.

. 2024 Apr;59(4):564-565.

doi: 10.1038/s41409-024-02201-w. Epub 2024 Jan 23.

¹ The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
² Blood and Marrow Transplant Program at Northside Hospital, Atlanta Georgia, GA, USA.
³ Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
⁴ Blood and Marrow Transplant Program at Northside Hospital, Atlanta Georgia, GA, USA. msolh@bmtga.com.

No abstract available

References

1. Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn KW, Chen M, et al. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood. 2016;127:2427–38. - DOI - PubMed - PMC
1. Eberhardt KA, Jung V, Knops E, Heger E, Wirtz M, Steger G, et al. CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality. Bone Marrow Transpl. 2023;58:639–46. - DOI
1. Limaye AP, Babu TM, Boeckh M. Progress and challenges in the prevention, diagnosis, and management of cytomegalovirus infection in transplantation. Clin Microbiol Rev. 2020;34:e00043–19. - DOI - PubMed - PMC
1. Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, et al. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med. 2017;377:2433–44. - DOI - PubMed
1. Zamora D, Duke ER, Xie H, Edmison BC, Akoto B, Kiener R, et al. Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation. Blood. 2021;138:34–43. - DOI - PubMed - PMC